A simple, quick one-step ELISA assay for the determination of complex plasma factor XII (A2B2)

Thrombosis and Haemostasis

Volumn 83, Issue 2, 2000, Pages 268-273

  Katona, Éva ^b   Haramura, Gizella ^b   Kárpáti, Levente ^b   Fachet, József ^b   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE

Author keywords

Factor XIII; Factor XIII ELISA; Factor XIII reference interval

Indexed keywords

BLOOD CLOTTING FACTOR 13; MONOCLONAL ANTIBODY; PEROXIDASE; PROTEIN SUBUNIT; STREPTAVIDIN;

ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD LEVEL; BLOOD SAMPLING; BLOOD STORAGE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; REPRODUCIBILITY; TIME;

EID: 0033973068     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613798     Document Type: Article

References (36)

1. Muszhek L. Ádány R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996; 33: 357-421.
2. Saito M, Asakura H, Yoshida T, Ito K, Okafuji K, Yoshida T, Matsuda T. A familial factor XIlI subunit B deficiency. Br J Haematol 1990; 74: 290-4.
3. Tosetto A, Castaman G, Rodeghiero F. Abnormal plasma factor XIII subunit A with fully functional platelet FXIII in a family with congenital deficiency of FXIII subunit B. Thromb Haemost 1993; 69: 1295a.
4. Izumi T, Hashiguchi T, Castaman G, Tosetto A, Rodeghiero F, Girolami A, Ichinose A. Type I factor XIII deficiency is caused by a genetic defect of its B subunit: Insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. Blood 1996; 87: 2769-74.
5. Lorand L, Losowsky MS, Miloszewski KJA. Human factor XIII: fibrinstabilising factor. Prog Haemost Thromb 1980; 5: 245-90.
6. Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 7: 229-42.
7. Egbring R, Kröniger A, Seitz. Factor XIII deficiency: Pathogenic mechanisms and clinical significance. Sem Thromb Hemost 1996; 22: 419-25.
8. Muszhek L, Polgár J, Fésüs L. Kinetic determination of blood coagulation factor XIII in plasma. Clin Chem 1985; 31: 35-40.
9. Fickenscher K, Aab A, Stuber W. A photometric assay for blood coagulation factor XIII. Thromb Haemost 1991; 65: 535-40.
10. Lorand L, Urayama T, deKiewiet JWC, Nossel HL. Diagnostic and genetic studies on fibrin-stabilising factor with a new assay based on amine incorporation. J Clin Invest 1969; 48: 1054-64.
11. Lorand L, Campbell-Wilkes LK, Cooperstein L. A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem 1972; 50: 623-31.
12. Song YC, Sheng D, Taubenfeld SM, Matsueda GR. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Anal Biochem 1994; 223: 88-92.
13. Barbui T, Rodeghiero F. Dini E, Mariani G, Papa ML, de Biasi R, Cordero Murillo R, Montera Umana C. Subunit A and S inheritance in four families with congenital factor XIII deficiency. Brit J Haematol 1978; 38: 267-71.
14. Skrzynia C, Reisner HM, McDonagh J. Characterisation of the catalytic subunit of factor XIII by radioimmunoassay. Blood 1982; 60: 1089-95.
15. Ikematsu S, McDonagh RP, Reisner HM, Skrzynia C, McDonagh J. Immunochemical studies of human factor XIII. Radioimmunoassay for the carrier subunit of the zymogen. J Lab Clin Med 1981; 97: 662-71.
16. Yorifuji H, Andersson K, Lynch GV, Van De Water L, McDonagh J. B protein of factor XIII: Differentiation between free B and complexed B. Blood 1988; 72: 1645-50.
17. Murdock PJ, Owens DL, Chitolie A, Hutton RA, Lee CA. Development and evaluation of ELISAs for factor XIIIA and XIIIB subunits in plasma. Thromb Res 1992; 67: 73-9.
18. Lorand L, Credo RB, Janus TJ. Factor XIII (fibrin stabilizing factor). Methods Enzymol 1981; 80: 333-41.
19. Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-407.
20. McDonagh J, Waggoner WG, Hamilton EG, Hindenach B. McDonagh RP. Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose. Biochim Biophys Acta 1976; 446: 345-57.
21. Bohn H, Schwick HG. Isolierung und Charakterisierung eines fibrinstabilisierenden Faktors aus menschlichen Plazenten. Arzneim Forsch 1971; 21: 1432-9.
22. Polgár J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placental macrophage factor XIII). Biochem J 1990; 267: 557-60.
23. Stahli C, Staehelin T, Miggiano V, Schmidt J, Haring P. High frequencies of antigen specific hybridomas: Dependence on immunisation parameters and prediction by spleen cell analysis. J Immunol Methods 1980; 32: 297-309.
24. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody predefined specificity. Nature 1975; 256: 495-506.
25. O'Shannessy DJ. Antibodies biotinylated via sugar moieties. Methods Enzymol 1990; 184: 162-6.
26. Wilson MB, Nakane PK. Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In: Immunofluorescence Related Staining Techniques. Knapp W, Holubar K, Wick G, eds. Amsterdam: Elsevier 1978; 215-20.
27. Kárpáti L, Muszbek L. An improved photometric assay for the determination of blood coagulation factor XIII in plasma. International Congress on Pediatric Laboratory Medicine. Abstract Book 1998; p 29.
28. Kohler HP, Stickland, Ossei-Gerning N, Carter A, Mikkola H, Grant P. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
29. Catto JA, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant P. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
30. Seitz R, Duckert S, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U, Study Group. ETRO Working Party on factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Sem Thromb Hemost 1996; 22: 415-8.
31. Anwar R, Gallivan L, Edmonds SD, Markham AF. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897-905.
32. Greenberg CS, Shuman MA. The zymogen form of blood coagulation factor XIII hinds specifically to fibrinogen. J Biol Chem 1982; 257: 6096-101.
33. Mikkola H, Muszbek L, Laiho E, Syrjälä M, Hämäläinen E, Haramura G, Salmi T, Peltonen L, Palotic A. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997; 89: 1279-87.
34. Miloszewski KJA, Losowsky MS. The half life of factor XIII in vivo. Br J Haematol 1978; 38: 267-71.
35. Fear JD, Miloszewski KJA, Losowsky MS. The half life of factor XIII in the management of inherited deficiency. Thromb Haemost 1983; 49: 102-5.
36. Rodeghiero F, Tosetto A, Di Bona E, Castaman G. Clinical pharmacokinetics of placenta derived factor XIII concentrate in type I and type II factor XIII deficiency. Am J Haematol 1991; 36: 30-4.